Nanophase Announces Rights Offering to Stockholders
ROMEOVILLE, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB:NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a rights offering to existing holders of its common stock, par value $0.01 per share. Nanophase expects to receive gross proceeds of approximately $2.0 million, less expenses of the rights offering.
Related news for (NANX)
- Nanophase Reports Record Second Quarter Revenue and Profit
- Nanophase Technologies Announces Second Quarter 2024 Financial Release and Conference Call Details
- Solésence Beauty Science Wins Cosmopack North America Formulation Award for Third Year in a Row
- Solésence Beauty Science and other Chicago Innovation Awards Winners to Ring the Nasdaq Opening Bell
- Nanophase Reports Record First Quarter Results